, Australia

Extracorporeal life support devices rises in use in Australia

It played a major role in treating high risk COVID-19 patients.

A rise in the incidence of acute respiratory distress syndrome (ARDS) as more patients suffer from severe COVID-19 infection has driven the growth of Australia’s extracorporeal membrane oxygenation (ECMO) devices market, which is expected to grow at a CAGR of about 6% between 2021 and 2025, according to GlobalData.

The market rose 25% between 2019 and 2020. Two companies accounted for around 80% of the total market in 2020. “ECMO devices are playing a major role in treating high risk COVID-19 infected patients,” GlobalData’s medical devices analyst Tanisha Verma commented.

ECMO remains reserved for patients requiring critical interventional therapy due to the inability to oxygenate the blood, maintain adequate tissue perfusion with oxygenated blood, or both. Due to the risks associated with such procedures, its usage for non-critical patients remains unlikely.

“Factors such as high cost, lack of sufficient trained staff, complications such as blood clots, limb ischemia and difficulty in mitigating bleeding disorders during ECMO procedures need to be addressed to increase the market penetration of these devices in future,” Verma said.

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox

Find out who won at this year's Healthcare Asia Awards and Healthcare Asia Pharma Awards 

The event was held via video conferencing that started last 15 April.

What investment opportunities await for India’s health-tech space?

Before the pandemic, the industry focussed on wearables, lifestyle-linked problems, and more.

Singapore’s Tan Tock Seng Hospital closes wards to visitors

Two patients and two staff were infected by COVID-19.

Hygeia Healthcare buys 100% stake in Etern Group for $268m

The acquisition indirectly holds 98% of Suzhou Yongding Hospital in Jiangsu.

How reach52 bridges the gap in healthcare with tech

The unique startup aims to connect to 250 million individuals across the globe by 2030.

He Health bags internet hospital license in China

The online platform offers services such as men’s health consultations.

Indonesia's telehealth platform Halodoc bags $80m in funding

The funds will be used to deepen its penetration in key healthcare verticals in Indonesia.

South Korea eases requirements for drug imports

Pharmaceutical companies could benefit from the government’s drive to reduce regulatory uncertainty.

Taiwan's novel pharma products hit by low reimbursement prices

The low rates are discouraging the launch of new innovative products, insiders say.

Japan's liver cancer surveillance program hailed as world's best

The country established the programme for early detection of HCC in the 1980s.